Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

0.2717
Delayed Data
As of Jun 09
 -0.0083 / -2.96%
Today’s Change
0.15
Today|||52-Week Range
2.77
-76.97%
Year-to-Date
Aridis (ARDS) Up After FDA Nod for Pneumonia Drug Study Design
Jun 01 / Zacks.com - Paid Partner Content